JM Dutton & Associates Announces Investment Opinion on Aastrom Biosciences: Aastrom Biosciences Strong Speculative Buy Rating Maintained in Update Report by Dutton & Associates.Business Editors NOTE TO EDITORS: The following is an investment opinion issued by JM Dutton & Associates EL DORADO El Dorado, legendary country of South America El Dorado (ĕl`dərä`dō, –rā`–) [Span.,=the gilded man], legendary country of the Golden Man sought by adventurers in South America. HILLS, Calif.--(BUSINESS WIRE)--Nov. 18, 2003 JM Dutton & Associates continues coverage of Aastrom Biosciences (Nasdaq:ASTM ASTM abbr. American Society for Testing and Materials ) with its update report maintaining a Strong Speculative Buy rating. The 7-page report by JM Dutton senior analyst Sherry Grisewood, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , is available at www.jmdutton.com as well as from Bloomberg, Zacks, First Call, Multex, and other leading financial portals Financial Portal A website that provides a variety of financial data and information, acting as an information hub for clients who are individual investors requiring timely financial news and data to make their investment decisions. . Aastrom Biosciences is within weeks of achieving a company-defining milestone: the enrollment of the first patient in clinical trials for a tissue repair and regeneration Regeneration (biology) The process by which an animal restores a lost part of its body. Broadly defined, the term can include wound healing, tissue repair, and many kinds of restorative activities. product combining Aastrom's therapeutic cells with a biologically compatible delivery system. We suspect that the news of the start of both US and European clinical trials with a biologically active, cell-based therapy for bone regeneration will catch some in the orthopedics orthopedics (ôrthəpē`dĭks), medical specialty concerned with deformities, injuries, and diseases of the bones, joints, ligaments, tendons, and muscles. industry by surprise. Therefore, we view the recent consolidation of Aastrom's stock as a buying opportunity and are maintaining our Strong Speculative Buy rating. In light of the Company's progress, we are also initiating a new 12-month target of $2.50. Our update report also highlights a number of other important recent events. About Dutton & Associates Dutton & Associates is one of the largest independent investment research firms in the U.S. Its 21 senior analysts, primarily CFAs, have expertise in many industries. Dutton & Associates provides bias-free, continuing analyst coverage of over 60 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors. The cost of enrollment in our one-year continuing research program is US $28,000 prepaid pre·pay tr.v. pre·paid, pre·pay·ing, pre·pays To pay or pay for beforehand. pre·pay  ment n. before commencement of our research activities. We
received $22,000 from the Company for coverage for the year, and do not
accept payment of our fees in company stock. Our principals and analysts
are prohibited pro·hib·it tr.v. pro·hib·it·ed, pro·hib·it·ing, pro·hib·its 1. To forbid by authority: Smoking is prohibited in most theaters. See Synonyms at forbid. 2. from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion